Disodium Folinate

6 trials 3 recruiting VVarious

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

3 Completed trials

4 Sponsors

13 Countries

Phase III

Phase II

Phase III: 3 Phase II: 3

Indications tested

Gastrooesophageal cancer 1 HER2 positive gastric cancer 1

Sponsors using this IMP

Bristol-Myers Squibb Services Unlimited Company 2 Charite Universitaetsmedizin Berlin KöR 2 Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH 1 Scandion Oncology A/S 1

All trials

6 total

Pre-Operative Treatment in rEseCTable cOlon canceR (PROTECTOR/FIRE-10; AIO-KRK-0620; IAG-VO-0323) Prospective, randomized, open-label, multi… Recruiting

2023-508076-11-00 Phase III 1 country Charite Universitaetsmedizin Berlin KöR
Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized,… Recruiting

2024-512174-10-00 Phase III 1 country Charite Universitaetsmedizin Berlin KöR
Pan tumor Roll Over Study Recruiting

2023-506914-32-00 Phase II 10 countries Bristol-Myers Squibb Services Unlimited Company
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarci… Ended

2024-513610-34-00 Phase II 1 country Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
A Phase 2 Trial of SCO-101 in combination with FOLFIRI for Patients with Metastatic Colorectal Cancer (mCRC) with acquired Resistance to FOL… Ended

2024-518877-33-00 Phase II 1 country Scandion Oncology A/S
Nivo versus Nivo/Ipi or versus other chemotherapies to treat colorectal cancer Ended

2023-503956-29-00 Phase III 12 countries Bristol-Myers Squibb Services Unlimited Company

Showing 1–6 of 6 trials

← All drugs A–Z